Improved therapies for tuberculosis will require the careful revision of complex, multi-drug regimens. In this issue of Cell Systems, Larkins-Ford et al. integrate extensive dose-response measurements of drug combinations, in vivo animal data, and computational analysis to provide a new predictive framework for the prioritization of specific antitubercular drug regimens.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cels.2021.10.005 | DOI Listing |
Publication Analysis
Top Keywords
drug combinations
8
consequential drug
4
combinations tuberculosis
4
tuberculosis treatments
4
treatments improved
4
improved therapies
4
therapies tuberculosis
4
tuberculosis will
4
will require
4
require careful
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!